Chronic monoamine oxidase-B inhibitor treatment blocks monoamine oxidase-A enzyme activity
OPEN ACCESS
Loading...
Author / Producer
Date
2014-04
Publication Type
Journal Article
ETH Bibliography
yes
Citations
Altmetric
OPEN ACCESS
Data
Rights / License
Abstract
Patients with Parkinson’s disease receive selective irreversible monoamine oxidase (MAO)-B inhibitors, but their effects on MAO-A activity are not known during long-term application. We determined MAO-A inhibition in plasma samples from patients with MAO-B inhibitor intake or without MAO-B inhibitor treatment and from healthy controls. We detected a 70 % reduction of MAO-A activity in patients with MAO-B inhibitor therapy in comparison to the other groups. Our results suggest that treatment with MAO-B inhibitor may also influence MAO-A activity in vivo, when administered daily.
Permanent link
Publication status
published
External links
Editor
Book title
Journal / series
Volume
121 (4)
Pages / Article No.
379 - 383
Publisher
Springer
Event
Edition / version
Methods
Software
Geographic location
Date collected
Date created
Subject
Parkinson's disease; MAO-A; MAO-B inhibitors; Selegiline; Rasagiline
Organisational unit
Notes
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.